Ardelyx, Inc.

NasdaqGM:ARDX

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Drugstores & Retail Pharmacies

🌿 Fertilizers

💊 Pharmaceuticals

Location

United States

Market Cap

USD 1.10 B

Share Price

USD 4.60

Avg Daily Volume

5,388,045

Change (1 day)

2.68%

Change (1 year)

-17.27%

Change (YTD)

-9.27%

Ardelyx, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -47.54 M

Ardelyx, Inc. Operating Cash Flow is USD -47.54 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -41.04% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Ardelyx, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -80.64 M, a -7.54% change year over year.
Ardelyx, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -87.22 M, a -35.85% change year over year.
Ardelyx, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -135.95 M, a 35.00% change year over year.
Ardelyx, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -100.71 M, a 19.15% change year over year.

Competitors

BioMarin Pharmaceutical Inc.

USD 59.67

BMRN

+1.68 2.90%

Kyowa Kirin Co., Ltd.

USD 17.13

4151.T

+0.08 0.47%

Abbott India Limited

USD 401.64

ABBOTINDIA.NS

+3.20 0.80%

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 4.66

002422.SZ

+0.00 0.03%

SCHOTT Pharma AG & Co. KGaA

USD 29.88

1SXP.F

+0.05 0.15%

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

USD 7.52

688336.SS

+0.21 2.89%

Livzon Pharmaceutical Group Inc.

USD 3.72

1513.HK

-0.06 -1.52%

China Medical System Holdings Limited

USD 1.60

0867.HK

+0.05 3.29%

Chengdu Kanghong Pharmaceutical Group Co., Ltd

USD 4.02

002773.SZ

-0.09 -2.19%

Gland Pharma Limited

USD 21.93

GLAND.NS

-0.10 -0.44%

Jilin Aodong Pharmaceutical Group Co., Ltd.

USD 2.37

000623.SZ

-0.02 -0.90%

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.61

600062.SS

-0.01 -0.30%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

USD 1.51

603707.SS

-0.02 -1.54%

Beijing Aosaikang Pharmaceutical Co., Ltd.

USD 2.66

002755.SZ

+0.07 2.65%

Yifan Pharmaceutical Co., Ltd.

USD 1.95

002019.SZ

-0.04 -2.11%

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

USD 0.69

9989.HK

-0.01 -0.91%

Concord Biotech Limited

USD 21.25

CONCORDBIO.NS

+0.34 1.63%

China Resources Boya Bio-pharmaceutical Group Co., Ltd.

USD 3.65

300294.SZ

+0.00 0.07%

Neuland Laboratories Limited

USD 139.77

NEULANDLAB.NS

+3.24 2.37%

Faes Farma, S.A.

USD 5.31

FAE.MC

+0.02 0.40%

Key Data

Date	Operating Cash Flow	Capital Expenditure	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities